Generic placeholder image

Current Hypertension Reviews

Eiditor-in-Chief

ISSN (Print): 1573-4021
ISSN (Online): 1875-6506

Role of WNK Kinases in Blood Pressure Control

Author(s): Sung-Sen Yang, Shih-Hua Lin and Chou-Long Huang

Volume 4 , Issue 3 , 2008

Page: [161 - 166] Pages: 6

DOI: 10.2174/157340208785132617

Price: $58

Abstract

With-No-Lysine [K] (WNK) kinases are a group of serine/threonine protein kinases with an unusual location of the catalytic lysine. There are four mammalian WNK kinases, WNK1-4, each encoded by a separate gene. In addition, WNK1 has two alternatively spliced isoforms: a ubiquitously expressed full-length long isoform (L-WNK1) with kinase activity and a kidney-specific isoform (KS-WNK1) lacking kinase activity. Mutations of WNK1 and WNK4 genes cause a genetic hypertension syndrome, pseudohypoaldosteronism type 2 (PHA2). Recent studies show that WNK1, 3 and 4 are expressed in the aldosterone-sensitive distal tubules of kidney and contribute to sodium (Na+) and potassium (K+) homeostasis by regulating tubular Na+ and K+ transporters in complex manners. Mice with heterozygous disruption of WNK1 gene have hypotension but without apparent renal Na+ wasting. L-WNK1 is also expressed in heart and blood vessel. Thus, function of WNK1 in cardiovascular system may also contribute to blood pressure regulation. Transgenic or knockin mice carrying a disease-causing WNK4 gene exhibit typical phenotypes of PHA2 by increasing renal Na+ reabsorption. The review summarizes recent studies on the mechanism of WNK kinases regulation of Na+ homeostasis and cardiovascular function and the role in blood pressure control.

Keywords: WNK kinase, blood pressure, ion homeostasis, pseudohypoaldosteronism type 2 (PHA2)


Rights & Permissions Print Export Cite as
Related eBooks
Article Metrics
1
Related Articles
© 2020 Bentham Science Publishers